Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy.
Navadurong H, Prasoppokakorn T, Siriwong N, Phathong C, Teeyapun N, Tanasanvimon S, Thanapirom K, Komolmit P, Tangkijvanich P, Treeprasertsuk S, Chaiteerakij R. Navadurong H, et al. Among authors: teeyapun n. World J Gastrointest Oncol. 2023 Oct 15;15(10):1771-1783. doi: 10.4251/wjgo.v15.i10.1771. World J Gastrointest Oncol. 2023. PMID: 37969413 Free PMC article.
Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment.
Wanchaijiraboon P, Teeyapun N, Pakvisal N, Sainamthip P, Susiriwatananont T, Zungsontiporn N, Suntronwong N, Vichaiwattana P, Klinsawat W, Wanlapakorn N, Tanasanvimon S, Sriuranpong V, Poovorawan Y, Luangdilok S. Wanchaijiraboon P, et al. Among authors: teeyapun n. Vaccines (Basel). 2022 Oct 5;10(10):1662. doi: 10.3390/vaccines10101662. Vaccines (Basel). 2022. PMID: 36298528 Free PMC article.
Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients.
Prayongrat A, Noppaving P, Chobarporn T, Sudhinaraset N, Teeyapun N, Pakvisal N, Jantarabenjakul W, Sophonphan J, Lertbutsayanukul C, Poovorawan Y. Prayongrat A, et al. Among authors: teeyapun n. Vaccines (Basel). 2023 Jun 23;11(7):1135. doi: 10.3390/vaccines11071135. Vaccines (Basel). 2023. PMID: 37514951 Free PMC article.
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine.
Luangdilok S, Wanchaijiraboon P, Pakvisal N, Susiriwatananont T, Zungsontiporn N, Sriuranpong V, Sainamthip P, Suntronwong N, Vichaiwattana P, Wanlapakorn N, Poovorawan Y, Teeyapun N, Tanasanvimon S. Luangdilok S, et al. Among authors: teeyapun n. Vaccines (Basel). 2022 Sep 26;10(10):1613. doi: 10.3390/vaccines10101613. Vaccines (Basel). 2022. PMID: 36298478 Free PMC article.
Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study.
Teeyapun N, Luangdilok S, Pakvisal N, Sainamthip P, Mingmalairak S, Poovorawan N, Sitthideatphaiboon P, Parinyanitikul N, Sriuranpong V, Namkanisorn T, Inthasuwan P, Angspatt P, Wongchanapat P, Bamrungnam A, Leeleakpai N, Uttha S, Jaichum S, Kongkaew P, Suksanong C, Veranitinun R, Prasomphol A, Sartsuk C, Patcharajutanon C, Preaprang S, Choengsamor H, Phongwan R, Preeyasaksa C, Phaibulvatanapong E, Suntronwong N, Yorsaeng R, Vichaiwattana P, Wanlapakorn N, Kerr SJ, Poovorawan Y, Wanchaijiraboon P, Tanasanvimon S. Teeyapun N, et al. EClinicalMedicine. 2022 Oct;52:101608. doi: 10.1016/j.eclinm.2022.101608. Epub 2022 Aug 11. EClinicalMedicine. 2022. PMID: 35971500 Free PMC article.
Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study.
Archwamety A, Teeyapun N, Siripoon T, Poungvarin N, Tanasanvimon S, Sirachainan E, Akewanlop C, Korphaisarn K. Archwamety A, et al. Among authors: teeyapun n. Front Oncol. 2022 Feb 15;12:813009. doi: 10.3389/fonc.2022.813009. eCollection 2022. Front Oncol. 2022. PMID: 35242708 Free PMC article.
Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls.
Pakvisal N, Sainamthip P, Teeyapun N, Luangdilok S, Wanlapakorn N, Yorsaeng R, Poovorawan Y, Pakvisal P, Susiriwatananont T, Zungsontiporn N, Sriuranpong V, Tanasanvimon S, Wanchaijiraboon P. Pakvisal N, et al. Among authors: teeyapun n. Hum Vaccin Immunother. 2022 Nov 30;18(6):2094149. doi: 10.1080/21645515.2022.2094149. Epub 2022 Jul 1. Hum Vaccin Immunother. 2022. PMID: 35776836 Free PMC article.
Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac.
Wanchaijiraboon P, Sainamthip P, Teeyapun N, Luangdilok S, Poovorawan Y, Wanlapakorn N, Tanasanvimon S, Sriuranpong V, Susiriwatananont T, Zungsontiporn N, Pakvisal N. Wanchaijiraboon P, et al. Among authors: teeyapun n. Vaccines (Basel). 2023 Feb 3;11(2):356. doi: 10.3390/vaccines11020356. Vaccines (Basel). 2023. PMID: 36851234 Free PMC article.